Trump’s Proposed Pharma Tariffs Could Hit India Hard

US President Trump’s proposed major tariffs on pharmaceutical imports may significantly affect India, the world’s largest supplier of generics. With India exporting $9.7 billion worth of drugs to the US, tariffs could raise production costs and reduce price competitiveness. US consumers may face higher drug prices, with generics rising up to $0.12 per pill.